oxycodone and e-52862

oxycodone has been researched along with e-52862 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Alegret, C; Almansa, C; Alonso, M; Fernández, B; García, M; Monroy, X; Pascual, R; Port, A; Serafini, MT; Vela, JM; Vidal-Torres, A; Virgili, M1
Alegret, C; Almansa, C; Alonso, M; Ayet, E; Bordas, M; Burgueño, J; Farran, J; Fernández de Henestrosa, AR; Fernández, B; García, M; Merlos, M; Pascual, R; Plata-Salamán, CR; Vela, JM; Vidal-Torres, A; Virgili, M1
Almansa, C; Ayet, E; Bordas, M; Burgueño, J; Christmann, U; Dordal, A; Fernández, B; García, M; Garriga, L; Gris, G; Llorente, V; Portillo-Salido, E; Pujol, M; Rodríguez-Escrich, S; Vela, JM; Virgili, M1

Other Studies

3 other study(ies) available for oxycodone and e-52862

ArticleYear
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Alkanes; Analgesics; Analgesics, Opioid; Animals; Humans; Male; Mice; Models, Molecular; Pain; Pain Management; Receptors, Opioid, mu; Receptors, sigma; Sigma-1 Receptor; Spiro Compounds

2020
Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    Topics: Administration, Oral; Analgesics, Opioid; Animals; Binding Sites; Blood-Brain Barrier; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Half-Life; Ligands; Male; Mice; Molecular Dynamics Simulation; Pain; Receptors, Opioid, mu; Receptors, sigma; Sigma-1 Receptor; Spiro Compounds; Structure-Activity Relationship

2020
Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ
    Journal of medicinal chemistry, 2021, 07-22, Volume: 64, Issue:14

    Topics: Amides; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Narcotic Antagonists; Pain; Receptors, Opioid, mu; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship

2021